Paige A. Taylor, PH.D.

Peer-Reviewed Articles

1. Hartzell, S, Guan, F, Magro, G, Taylor, PA, Taddei, PJ, Peterson, CB, Kry, SF. Contribution of Nuclear Fragmentation to Dose and RBE in Carbon-Ion Radiotherapy. Radiation research 203(2):96-106, 2025. e-Pub 2025. PMID: 39862066.
2. Taylor, PA, Mirandola, A, Ciocca, M, Hartzell, S, Vai, A, Alvarez, PE, Howell, RM, Koay, EJ, Peeler, CR, Peterson, CB, Kry, SF. Technical note. Medical physics 51(7):5154-5158, 2024. e-Pub 2024. PMID: 38598230.
3. Faddegon B, Descovich M, Chen K, Ramos-Méndez J, Iii MR, Wahl N, Taylor P, Griffin K, Lee C. A digital male pelvis phantom series showing anatomical variations over the course of fractionated radiotherapy treatment. Med Phys 51(4):3034-3044, 2024. e-Pub 2023. PMID: 38071746.
4. Shen, J, Taylor, PA, Vargas, C, Kang, M, Saini, J, Zhou, J, Wang, P, Liu, W, Simone, C, Xiao, Y, Lin, L. The Status and Challenges for Prostate Stereotactic Body Radiation Therapy Treatments in United States Proton Therapy Centers. International Journal of Particle Therapy 11, 2024. e-Pub 2024. PMID: 38757080.
5. Zou W, Zhang R, Schüler E, Taylor PA, Mascia AE, Diffenderfer ES, Zhao T, Ayan AS, Sharma M, Yu SJ, Lu W, Bosch WR, Tsien C, Surucu M, Pollard-Larkin JM, Schuemann J, Moros EG, Bazalova-Carter M, Gladstone DJ, Li H, Simone CB, Petersson K, Kry SF, Maity A, Loo BW, Dong L, Maxim PG, Xiao Y, Buchsbaum JC. Framework for Quality Assurance of Ultrahigh Dose Rate Clinical Trials Investigating FLASH Effects and Current Technology Gaps. Int J Radiat Oncol Biol Phys 116(5):1202-1217, 2023. e-Pub 2023. PMID: 37121362.
6. Taylor PA, Miles E, Hoffmann L, Kelly SM, Kry SF, Sloth Møller D, Palmans H, Akbarov K, Aznar MC, Clementel E, Corning C, Effeney R, Healy B, Moore A, Nakamura M, Patel S, Shaw M, Stock M, Lehmann J, Clark CH. Prioritizing clinical trial quality assurance for photons and protons: A failure modes and effects analysis (FMEA) comparison. Radiother Oncol 182:109494, 2023. e-Pub 2023. PMID: 36708923.
7. Taylor, P A, Miles, E, Hoffmann, L, Kelly, S M, Kry, S F, Møller S, D, Palmans, H, Akbarov, K, Aznar, M C, Clementel, E, Corning, C, Effeney, R, Healy, B, Moore, A, Nakamura, M, Patel, S, Shaw, M, Stock, M, Lehmann, J, Clark, C H. Prioritizing clinical trial quality assurance for photon and protons: A failure modes and effect analysis (FMEA) comparison. Radiotherapy and Oncology 182(109494), 2023. e-Pub 2023.
8. Mehrens H, Taylor P, Alvarez P, Kry S. Analysis of Performance and Failure Modes of the IROC Proton Liver Phantom. Int J Part Ther 10(1):23-31, 2023. e-Pub 2023. PMID: 37823015.
9. Zhu XR, Li Y, Yang M, Whitaker TJ, Taylor PA, Zhang X, Poenisch F, Sahoo N, Liao Z, Chang JY. Stereotactic body proton therapy for early stage non-small cell lung cancer - Technical challenges and solutions: The MD Anderson experience. J Radiosurg SBRT 9(1):75-82, 2023. e-Pub 2023. PMID: 38029015.
10. Maroongroge S, Pinnix CC, Wallington DG, Taylor PA, Zhu D, Guadagnolo BA, Smith BD, Yu JB, Ballas LK. In Reply to Smith et al. Int J Radiat Oncol Biol Phys 113(3):696-697, 2022. e-Pub 2022. PMID: 35777400.
11. Maroongroge S, Wallington DG, Taylor PA, Zhu D, Guadagnolo BA, Smith BD, Yu JB, Ballas LK. Geographic access to radiation therapy facilities in the United States. Int J Radiat Oncol Biol Phys 112(3):600-610, 2022. e-Pub 2022. PMID: 34762972.
12. Taylor PA, Lowenstein J, Followill D, Kry SF. The Value of On-Site Proton Audits. Int J Radiat Oncol Biol Phys 112(4):1004-1011, 2022. e-Pub 2022. PMID: 34780973.
13. Mehrens H, Nguyen T, Edward S, Hartzell S, Glenn M, Branco D, Hernandez N, Alvarez P, Molineu A, Taylor P, Kry S. The current status and shortcomings of stereotactic radiosurgery. Neurooncol Adv 4(1):vdac058, 2022. e-Pub 2022. PMID: 35664554.
14. Hartzell S, Guan F, Taylor P, Peterson C, Taddei P, Kry S. Uncertainty in tissue equivalent proportional counter assessments of microdosimetry and RBE estimates in carbon radiotherapy. Phys Med Biol 66(15), 2021. e-Pub 2021. PMID: 34252894.
15. Taylor PA, Alvarez PE, Mehrens H, Followill DS. Failure modes in IROC photon liver phantom irradiations. Pract Radiat Oncol 11(3):e322-e328, 2021. e-Pub 2020. PMID: 33271351.
16. Branco D, Kry S, Taylor P, Zhang X, Rong J, Frank S, Followill D. Dosimetric impact of commercial CT metal artifact reduction algorithms and a novel in-house algorithm for proton therapy of head and neck cancer. Med Phys 48(1):445-455, 2021. e-Pub 2020. PMID: 33176003.
17. Branco D, Kry S, Taylor P, Rong J, Zhang X, Frank S, Followill D. Evaluation of image quality of a novel computed tomography metal artifact management technique on an anthropomorphic head and neck phantom. Phys Imaging Radiat Oncol 17:111-116, 2021. e-Pub 2021. PMID: 33898789.
18. Lin L, Taylor PA, Shen J, Saini J, Kang M, Simone CB, Bradley JD, Li Z, Xiao Y. NRG oncology survey of monte carlo dose calculation use in US proton therapy centers. Int J Part Ther 8(2):73-81, 2021. e-Pub 2021. PMID: 34722813.
19. Arjomandy B, Taylor P, Ainsley C, Safai S, Sahoo N, Pankuch M, Farr JB, Yong Park S, Klein E, Flanz J, Yorke ED, Followill D, Kase Y. AAPM task group 224: Comprehensive proton therapy machine quality assurance. Med Phys 46(8):e678-e705, 2019. e-Pub 2019. PMID: 31125441.
20. Kang Y, Shen J, Liu W, Taylor PA, Mehrens HS, Ding X, Hu Y, Tryggestad E, Keole SR, Schild SE, Wong WW, Fatyga M, Bues M. Impact of planned dose reporting methods on Gamma pass rates for IROC lung and liver motion phantoms treated with pencil beam scanning protons. Radiat Oncol 14(1):108, 2019. e-Pub 2019. PMID: 31208439.
21. Wang P, Tang S, Taylor PA, Cummings DE, Janson M, Traneus E, Sturgeon JD, Lee AK, Chang C. Clinical examination of proton pencil beam scanning on a moving anthropomorphic lung phantom. Med Dosim 44(2):122-129, 2019. e-Pub 2019. PMID: 29759487.
22. Huang S, Souris K, Li S, Kang M, Barragan Montero AM, Janssens G, Lin A, Garver E, Ainsley C, Taylor P, Xiao Y, Lin L. Validation and application of a fast Monte Carlo algorithm for assessing the clinical impact of approximations in analytical dose calculations for pencil beam scanning proton therapy. Med Phys 45(12):5631-5642, 2018. e-Pub 2018. PMID: 30295950.
23. Kerns JR, Followill DS, Lowenstein J, Molineu A, Alvarez P, Taylor PA, Kry SF. Reference dosimetry data and modeling challenges for Elekta accelerators based on IROC-Houston site visit data. Med Phys 45(5):2337-2344, 2018. e-Pub 2018. PMID: 29537634.
24. Branco D, Taylor P, Zhang H, Li H, Guindani M, Followill D. An anthropomorphic head and neck quality assurance phantom for credentialing of intensity-modulated proton therapy. International Journal of Particle Therapy, 2018. e-Pub 2018.
25. Lewis DJ, Taylor PA, Followill DS, Sahoo N, Mahajan A, Stingo FC, Kry SF. A new anthropomorphic pediatric spine phantom for proton therapy clinical trial credentialing. Int J Part Ther 4(4):20-27, 2018. e-Pub 2018. PMID: 30214913.
26. Kry SF, Dromgoole L, Alvarez P, Leif J, Molineu A, Taylor P, Followill DS. Radiation therapy deficiencies identified during on-site dosimetry visits by the Imaging and Radiation Oncology Core Houston Quality Assurance Center. Int J Radiat Oncol Biol Phys 99(5):1094-1100, 2017. e-Pub 2017. PMID: 29029890.
27. Taylor PA, Kry SF, Followill DS. Pencil beam algorithms are unsuitable for proton dose calculations in lung. Int J Radiat Oncol Biol Phys 99(3):750-756, 2017. e-Pub 2017. PMID: 28843371.
28. Kerns JR, Followill DS, Lowenstein J, Molineu A, Alvarez P, Taylor PA, Kry SF. Agreement between institutional measurements and treatment planning system calculations for basic dosimetric parameters as measured by the Imaging and Radiation Oncology Core-Houston. Int J Radiat Oncol Biol Phys 95(5):1527-1534, 2016. e-Pub 2016. PMID: 27315667.
29. Martin MT, Telebak E, Taylor PA, Volozhina O. Development of a specialty medication prior-authorization service at an urban academic medical center. Am J Health Syst Pharm 73(15):1174-1179, 2016. e-Pub 2016. PMID: 27440624.
30. Taylor PA, Kry SF, Alvarez P, Keith T, Lujano C, Hernandez N, Followill DS. Results from the Imaging and Radiation Oncology Core Houston's anthropomorphic phantoms used for proton therapy clinical trial credentialing. Int J Radiat Oncol Biol Phys 95(1):242-248, 2016. e-Pub 2016. PMID: 27084644.
31. Kerns JR, Followill DS, Lowenstein J, Molineu A, Alvarez P, Taylor PA, Stingo FC, Kry SF. Technical Report: Reference photon dosimetry data for Varian accelerators based on IROC-Houston site visit data. Med Phys 43(5):2374, 2016. e-Pub 2016. PMID: 27147349.
32. Cho J, Summers PA, Ibbott GS. An anthropomorphic spine phantom for proton beam approval in NCI-funded trials. J Appl Clin Med Phys 15(3):252-265, 2014. e-Pub 2014. PMID: 24892351.
33. Grant RL, Summers PA, Neihart JL, Blatnica AP, Sahoo N, Gillin MT, Followill DS, Ibbott GS. Relative stopping power measurements to aid in the design of anthropomorphic phantoms for proton radiotherapy. J Appl Clin Med Phys 15(2):4523, 2014. e-Pub 2014. PMID: 24710437.
34. Moyers MF, Ibbott GS, Grant RL, Summers PA, Followill DS. Independent dose per monitor unit review of eight U.S.A. proton treatment facilities. Med Phys 41(1):012103-01 - 012103-5, 2014. e-Pub 2014. PMID: 24387521.
35. Iqbal K, Gillin M, Summers PA, Dhanesar S, Gifford KA, Buzdar SA. Quality assurance evaluation of spot scanning beam proton therapy with an anthropomorphic prostate phantom. Br J Radiol 86(1031):20130390, 2013. e-Pub 2013. PMID: 24049129.
36. Dhanesar S, Sahoo N, Kerr M, Taylor MB, Summers P, Zhu XR, Poenisch F, Gillin M. Quality assurance of proton beams using a multilayer ionization chamber system. Med Phys 40(9):092102-1 - 092102-9, 2013. e-Pub 2013. PMID: 24007171.
37. Tanyi JA, He T, Summers PA, Mburu RG, Kato CM, Rhodes SM, Hung AY, Fuss M. Assessment of planning target volume margins for intensity-modulated radiotherapy of the prostate gland: Role of daily inter- and intrafraction motion. Int J Radiat Oncol Biol Phys 5(78):1579-1585, 2010. e-Pub 2010. PMID: 20472357.

Other Articles

1. Xiao, Y, Benedict, SH, Cui, Y, Glide-Hurst, CK, Graves, S, Jia, X, Kry, SF, Li, H, Lin, L, Matuszak, MM, Newpower, M, Paganetti, H, Qi, XS, Roncali, E, Rong, Y, Sgouros, G, Simone, C, Sunderland, J, Taylor, PA, Tchelebi, LT, Weldon, M, Zou, JW, Wuthrick, EJ, Machtay, M, Le, QT, Buchsbaum, J Embracing the Future of Clinical Trials in Radiation Therapy. International Journal of Radiation Oncology Biology Physics 122(2):443-457, 2025. PMID: 39848295.
2. Paganetti, H, Simone, C, Bosch, WR, Haas-Kogan, D, Kirsch, DG, Li, H, Liang, X, Liu, W, Mahajan, A, Story, MD, Taylor, PA, Willers, H, Xiao, Y, Buchsbaum, J NRG Oncology White Paper on the Relative Biological Effectiveness in Proton Therapy. International Journal of Radiation Oncology Biology Physics 121(1):202-217, 2025. PMID: 39059509.
3. Liu, W, Feng, H, Taylor, PA, Kang, M, Shen, J, Saini, J, Zhou, J, Giap, H, Yu, NY, Sio, TS, Mohindra, P, Chang, JY, Bradley, JD, Xiao, Y, Simone, C, Lin, L NRG Oncology and Particle Therapy Co-Operative Group Patterns of Practice Survey and Consensus Recommendations on Pencil-Beam Scanning Proton Stereotactic Body Radiation Therapy and Hypofractionated Radiation Therapy for Thoracic Malignancies. International Journal of Radiation Oncology Biology Physics 119(4):1208-1221, 2024. PMID: 38395086.
4. Taylor PA, Moran JM, Jaffray DA, Buchsbaum JC A roadmap to clinical trials for FLASH. Med Phys 49(6):4099-4108, 2022. PMID: 35366339.
5. Kry SF, Lye J, Clark CH, Andratschke N, Dimitriadis A, Followill D, Howell R, Hussein M, Ishikawa M, Kito S, Kron T, Lee J, Michalski J, Filippo Monti A, Reynaert N, Taylor P, Venables K, Xiao Y, Lehmann J Report dose-to-medium in clinical trials where available; a consensus from the global Harmonisation group to maximize consistency. Radiother Oncol 159:106-111, 2021. PMID: 33741471.
6. Yock AD, Mohan R, Flampouri S, Bosch W, Taylor PA, Gladstone D, Kim S, Sohn J, Wallace R, Xiao Y, Buchsbaum J Robustness analysis for external beam radiation therapy treatment plans: describing uncertainty scenarios and reporting their dosimetric consequences. Pract Radiat Oncol 9(4):200-207, 2019. PMID: 30562614.

Editorials

1. Garibaldi, C, Beddar, S, Bizzocchi, N, Tobias Böhlen, T, Iliaskou, C, Moeckli, R, Psoroulas, S, Subiel, A, Taylor, PA, Van den Heuvel, F, Vanreusel, V, Verellen, D. Minimum and optimal requirements for a safe clinical implementation of ultra-high dose rate radiotherapy. Radiotherapy and Oncology 196, 2024. PMID: 38648991.

Abstracts

1. Carson ME, Molineu A, Taylor PA, Followill DS, Stingo FC, Kry SF. Examining credentialing criteria and poor performance indicators for IROC Houston's anthropomorphic head and neck phantom. Med Phys 43(12):3841, 2016. e-Pub 2016. PMID: 27908168.
2. Lee P, Alvarez P, Taylor P, Lowenstein J, Molineu A, Kry S, Followill D. An analysis of TG-51 electron beam calibration correction factor uncertainty. Med Phys 42(6):3353-3354, 2015. e-Pub 2015.
3. Arjomandy B, Klein E, Taylor P, Ainsley C, Safai S, Sahoo N, Pankuch M, Park S, Farr J, Kase Y, Flanz J, Yorke E, Followill D. Quality assurances for proton therapy delivery equipment. Med Phys 42(6):3485-3486, 2015. e-Pub 2015.
4. McInnis M, Taylor P, Poenisch F, Court L, Guindani M, Followill D. Uncertainties in treatment planning for IROC-Houston proton phantom QA program due to variable CT technique and proton energy. Med Phys 42(6):3515, 2015. e-Pub 2015.
5. Lujano C, Hernandez N, Keith T, Nguyen T, Taylor P. IROC Houston QA Center's anthropomorphic proton phantom program. Med Phys 42(6):3580-3581, 2015. e-Pub 2015.
6. Taylor P, Lowenstein J, Kry S, Ibbott G, Followill D. A comparison of CT number to relative linear stopping power conversion curves used by proton therapy centers. Med Phys 42(6):3616, 2015. e-Pub 2015.
7. Schulte R, Choy H, P T, Lee C. Clinical trials in proton and particle therapy. Med Phys 42(6):3629, 2015. e-Pub 2015.
8. Taylor P. IROC Houston's proton beam validation for clinical trials. Med Phys 42(6):3629, 2015. e-Pub 2015.
9. Followill D, Kry S, Molineu A, Lowenstein J, Alvarez P, Taylor P, Nguyen H, Hernandez N, Lujano C, Nguyen T, Keith T, Roll J, Tailor A. The Imaging and Radiation Oncology Core Houston (IROC Houston) QA Center international activities outside North America. Med Phys 42(6):3628, 2015. e-Pub 2015.
10. Kry S, Dromgoole L, Alvarez P, Lowenstein J, Molineu A, Taylor P, Followill D. Common errors and deficiencies in radiation oncology practice. Med Phys 42(6):3691-3692, 2015. e-Pub 2015.
11. Kry S, Dromgoole L, Alvarez P, Lowenstein J, Molineu A, Taylor P, Followill D. IROC Houston on-site audits and parameters that affect performance. Med Phys 42(6):3692, 2015. e-Pub 2015.
12. Sloboda R, Ballester F, Tedgren Carlsson A, Culberson W, Esthappan J, Haworth A, Lowenstein J, Ma Y, Mourtada F, Papagiannis P, Pike T, Rivard M, Siebert F, Smith R, Spadinger I, Taylor P, Verhaegen F, Vijande J, Beaulieu L. Infrastructure and process for model-based dose calculation software commissioning in brachytherapy. Med Phys 42(6):3708, 2015. e-Pub 2015.
13. Taylor P, Lowenstein J, Ibbott G, Alvarez A, Kry S, Molineu A, Followill D. A summary of findings from the IROC Houston proton therapy audit program. International Journal of Particle Therapy 2(1), 2015. e-Pub 2015.
14. Summers PA, Ibbott GS, Alvarez P, Moyers M, Lafratta R, Followill DS. Compilation of proton therapy data from the approval process for NCI-funded clinical trials. Int J Radiat Oncol Biol Phys 90(1), 2014. e-Pub 2014.
15. Neihart J, Sahoo N, Balter P, Summers P, Palmer M, Kerr M, Followill D. Design and verification of a heterogeneous proton equivalent thorax phantom for use in end to end assessment of pencil beam proton therapy. Med Phys 40(6):297, 2013. e-Pub 2013.
16. Dhanesar S, Sahoo N, Kerr M, Taylor M, Summers P, Alvarez P, Wu R, Poenisch F, Zhu X, Gillin M. Intensity modulated proton therapy plans with multiple fields for prostate cancer. Med Phys 40(6):422, 2013. e-Pub 2013.
17. Summers P, Ibbott G, Moyers M, Grant R, Followill D. Radiological Physics Center (RPC) approval of proton centers for NCI-sponsored clinical trials. Med Phys 40(6):548, 2013. e-Pub 2013.
18. Summers P. Comparison of clinical parameters for proton therapy in the United States. Int J Radiat Oncol Biol Phys, 2012. e-Pub 2012.
19. Summers P. Comparison of proton therapy institutional ata. Med Phys, 2012. e-Pub 2012.
20. Summers P. The RPC proton therapy approval process. Med Phys, 2012. e-Pub 2012.
21. Followill D, Lowenstein J, Molineu A, Alvarez P, Aguirre J, Kry S, Summers P, Ibbott G. The Radiological Physics Center's quality audit program. Med Phys 6(39):3866, 2012. e-Pub 2012.
22. Tonigan J, Kry S, Summers P, Balter P, Diel T, Followill D. The magnitude of head & neck IMRT dose delivery errors from three possible failure modes. Med Phys 39(6):3999, 2012. e-Pub 2012.
23. Lowenstein J, Kry S, Molineu A, Alvarez P, Aguirre J, Summers P, Followill D. High-energy photon standard dosimetry data. Med Phys 6(39):3754, 2012. e-Pub 2012.
24. Song X, Sahoo N, Wu R, Taylor M, Georges R, Zhu X, Summers P, Gillin M. Dosimetry of double scattered proton beam fields used for cranio-spinal irradiation. Med Phys 6(39):3770, 2012. e-Pub 2012.
25. Dhanesar S, Sahoo N, Taylor M, Song X, Poenisch F, Summers P, Li H, Zhu XR, Gillin M. Evaluation of Zebra multi-layer ionization chamber system for patient treatment field and machine QA for spot scanning and passive scattering proton beams. Med Phys 6(39):3613, 2012. e-Pub 2012.
26. Summers P, Followill D, Sahoo N, Poenisch F, Tucker S, Gillin M, Riley B, Ibbott G. Development of an anthropomorphic head phantom for the assessment of proton therapy treatment procedures. Med Phys, 2011. e-Pub 2011.

Book Chapters

1. Taylor PA. Credentialing Proton Centers for Clinical Trials. In: Proton Therapy - Current Status and Future Directions. IntechOpen, 2021.
2. Taylor PA. Clinical Trials Evaluating Proton Therapy. In: Proton Therapy - Current Status and Future Directions. IntechOpen, 2021.